文献速递心脑血管急症重症综合管理与镇静镇痛

无插管条件下氯胺酮治疗难治性癫痫发作的安全性与有效性:病例系列

Safety and Efficacy of Ketamine Without Intubation in the Management of Refractory Seizures: A Case Series.
PubMed 文献 · Neurocrit Care · 2023-08-23
一句话结论回顾性病例系列提示,未插管成人难治性癫痫发作使用氯胺酮持续输注,71.4%在24小时内发作缓解且无需插管或加用其他持续输注麻醉药,早期启用可能提高成功率。

该回顾性队列分析28例未插管成人难治性癫痫发作患者,研究氯胺酮输注的安全性与有效性。78.5%接受初始负荷量平均0.9 mg/kg,89.3%以10 μg/kg/分钟起始输注,中位持续时间39.8小时;71.4%为应答者(24小时内发作缓解且无需插管或加用其他持续输注麻醉药),8例无应答者中6例需插管并加用其他持续输注麻醉药。应答者接受氯胺酮比无应答者早5小时以上的可能性高80%。作者认为氯胺酮是难治性癫痫发作安全有效的治疗选择,在仔细选择的人群中可能减少插管相关并发症。

要点

  • 28例未插管成人难治性癫痫发作患者中,71.4%为氯胺酮应答者(24小时内发作缓解且无需插管或加用其他持续输注麻醉药)。
  • 8例无应答者中6例需要插管并加用其他持续输注麻醉药。
  • 应答者接受氯胺酮比无应答者早5小时以上的可能性高80%。
  • 仅用氯胺酮者低血压(收缩压<90 mmHg)发生率31.8%,与输注时长或最大剂量无关;高血压(收缩压>180 mmHg)发生率39.3%。
  • 最大输注速率:16例为10 μg/kg/分钟,7例为20 μg/kg/分钟,5例为30 μg/kg/分钟;中位持续时间39.8小时。

适用人群与场景

  • 成人难治性癫痫发作患者,在开始氯胺酮输注时未插管。
  • 中位年龄62岁,64.3%女性,82.1%非裔美国人,82.1%结构性癫痫病因,85.7%局灶性发作。

诊断标准与关键阈值

  • 应答者定义:开始氯胺酮后24小时内癫痫发作缓解,且无需插管或加用其他持续输注麻醉药。
  • 癫痫发作起始时间:首次临床发作或脑电图(EEG)报告的首次非惊厥性发作,或对EEG开始时即有发作的患者以EEG开始时间为起始时间。

处置流程与药物剂量

  • 78.5%患者接受初始负荷量,平均0.9 mg/kg。
  • 89.3%患者以10 μg/kg/分钟起始输注,中位持续时间39.8小时。
  • 最大输注速率:16例为10 μg/kg/分钟,7例为20 μg/kg/分钟,5例为30 μg/kg/分钟。

红旗征与不能漏的情况

  • 无应答者中6/8需要插管并加用其他持续输注麻醉药。

研究设计与关键结果

  • 回顾性队列研究,纳入28例未插管成人难治性癫痫发作患者,分析氯胺酮输注的安全性与有效性。
  • 71.4%患者评估为氯胺酮应答者;8例无应答者中6例需要插管并加用其他持续输注麻醉药。
  • 应答者接受氯胺酮比无应答者早5小时以上的可能性高80%。
  • 仅用氯胺酮者低血压(收缩压<90 mmHg)发生率31.8%,与输注持续时间或最大剂量无关;高血压(收缩压>180 mmHg)发生率39.3%。

证据类型、等级与局限

  • 证据类型:回顾性队列研究(病例系列)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为氯胺酮是难治性癫痫发作安全有效的治疗选择,在仔细选择的人群中可能减少插管相关并发症。
  • 作者认为早期启用氯胺酮可能提高治疗成功可能性。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Continuous infusion ketamine has demonstrated efficacy in the management of refractory seizures yet does not suppress respiratory drive like other continuous infusion anesthetics (CIAs) used for this indication. The aim of this study is to describe the safety and efficacy of ketamine infusions in patients with refractory seizure without intubation.

METHODS: We analyzed a retrospective cohort of adult patients who were not intubated at the time of initiation of a ketamine infusion for refractory seizures. Seizure onset was determined to be the first clinical seizure or nonconvulsive seizure reported on electroencephalography (EEG) or the start time of EEG for patients with seizures at EEG initiation. Responders were defined as patients with resolution of seizures within 24 h of initiation without the need for intubation or an additional CIA.

RESULTS: A total of 28 patients were analyzed (median age 62 years, 64.3% female, 82.1% African American, 82.1% with structural seizure etiology, and 85.7% focal seizures). Of patients, 78.5% received an initial bolus averaging 0.9 mg/kg, and the majority (89.3%) were initiated on an infusion at 10 μg/kg/minute; median duration was 39.8 h. Maximum infusion rates were 10 μg/kg/minute in 16 patients, 20 μg/kg/minute in seven patients, and 30 μg/kg/minute in five patients. Of patients, 71.4% were assessed to be ketamine responders; six of the eight nonresponders required intubation and an additional CIA. Responders were 80% more likely to have received ketamine 5 or more hours earlier than nonresponders. Hypotension (systolic blood pressure < 90 mmHg) occurred in 31.8% of patients receiving only ketamine, which did not correlate with duration or maximum dose of ketamine; hypertension (systolic blood pressure > 180 mmHg) occurred in 39.3%.

CONCLUSIONS: Ketamine represents a safe and effective treatment option for refractory seizures and has potential to reduce morbidity associated with intubation in a carefully selected patient population. Early initiation may increase the likelihood of success.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Kimmons LA, Alzayadneh M, Metter EJ, et al. Safety and Efficacy of Ketamine Without Intubation in the Management of Refractory Seizures: A Case Series. Neurocrit Care. 2023. PMID: 37610640. doi:10.1007/s12028-023-01811-4

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。